MCKESSON 17/29MCKESSON 17/29MCKESSON 17/29

MCKESSON 17/29

No trades
See on Supercharts

XS156717452 analysis



Key facts


Issue date
Feb 17, 2017
Maturity date
Feb 17, 2029
Outstanding amount
‪450.00 M‬GBP
Face value
1,000.00GBP
Minimum denomination
100,000.00GBP
Coupon
3.13% (Fixed)
Yield to maturity
4.93%
McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs. The RxTS segment offers prescription price transparency, benefit insight, dispensing support services, third-party logistics, and wholesale distribution. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The International segment refers to the distribution and services to wholesale, institutional, and retail customers in Europe and Canada. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.